Gene therapy for the treatment of catecholaminergic polymorphic ventricular tachycardia

Circulation. 2014 Jun 24;129(25):2633-5. doi: 10.1161/CIRCULATIONAHA.114.010586. Epub 2014 Jun 2.
No abstract available

Keywords: Editorials; calsequestrin; genetic therapy; polymorphic catecholaminergic ventricular tachycardia; ryanodine receptor release channel; sarcoplasmic reticulum.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Aging*
  • Animals
  • Calsequestrin / genetics*
  • Dependovirus / genetics*
  • Female
  • Male
  • Polymorphic Catecholaminergic Ventricular Tachycardia
  • Tachycardia, Ventricular / therapy*

Substances

  • Calsequestrin
  • casq2 protein, mouse